Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy
Cardiotoxicity associated with chemotherapy, also known as Cancer Therapy-Related Cardiac Dysfunction (CTRCD), affects 10% of patients undergoing chemotherapy and is the most undesirable side effect of chemotherapy. Over time, it is anticipated that there would be an increase in the number of cancer...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2023-10-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | https://actamedindones.org/index.php/ijim/article/view/2440 |
| _version_ | 1827381681384849408 |
|---|---|
| author | Muhammad Yamin Simon Salim Muhammad Syahrir Azizi Lusiani Rusdi Aru Wisaksono Sudoyo Anneira Amanda Putri |
| author_facet | Muhammad Yamin Simon Salim Muhammad Syahrir Azizi Lusiani Rusdi Aru Wisaksono Sudoyo Anneira Amanda Putri |
| author_sort | Muhammad Yamin |
| collection | DOAJ |
| description | Cardiotoxicity associated with chemotherapy, also known as Cancer Therapy-Related Cardiac Dysfunction (CTRCD), affects 10% of patients undergoing chemotherapy and is the most undesirable side effect of chemotherapy. Over time, it is anticipated that there would be an increase in the number of cancer patients receiving treatments that could harm their cardiovascular systems. Physicians should choose whether to continue, halt, delay, or reduce the dose of chemotherapeutic drugs to reduce the impact of cardiotoxicity.
Cardiotoxicity screening and diagnosis need a variety of methods, primarily echocardiography to evaluate Left Ventricular Ejection Fraction (LVEF) and Global Longitudinal Strain (GLS). Depending on the clinical state, these procedures may be carried out prior to, during, or following chemotherapy. It’s critical to reduce cardiovascular risk factors and offer advice on leading a healthy lifestyle before giving cancer patients medicines.
There are a lot of cancer treatment facilities all around the world that don’t have evidence-based perspective cardiotoxicity scores to stratify the risk of cardiovascular problems caused by cancer therapy. Additionally, comorbid conditions like diabetes and hypertension are frequently present in cancer patients, which can have a significant impact on clinical outcomes and cancer treatment. Therefore, this article aims to discuss assessment methods, clinical practice guidance, and prevention of CTRCD. |
| first_indexed | 2024-03-08T14:07:48Z |
| format | Article |
| id | doaj.art-2d9c75f4f6714956be299da1143aaa1c |
| institution | Directory Open Access Journal |
| issn | 0125-9326 2338-2732 |
| language | English |
| last_indexed | 2024-03-08T14:07:48Z |
| publishDate | 2023-10-01 |
| publisher | Interna Publishing |
| record_format | Article |
| series | Acta Medica Indonesiana |
| spelling | doaj.art-2d9c75f4f6714956be299da1143aaa1c2024-01-15T04:28:06ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322023-10-01554631Advancing The Cardiovascular Care in Cancer Patients on ChemotherapyMuhammad Yamin0Simon Salim1Muhammad Syahrir Azizi2Lusiani Rusdi3Aru Wisaksono Sudoyo4Anneira Amanda Putri5Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, IndonesiaDivision of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, IndonesiaDivision of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, IndonesiaDivision of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, IndonesiaDivision of Hematology-Medical Oncology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, IndonesiaResearch Assistant, Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo National General Hospital, Jakarta, IndonesiaCardiotoxicity associated with chemotherapy, also known as Cancer Therapy-Related Cardiac Dysfunction (CTRCD), affects 10% of patients undergoing chemotherapy and is the most undesirable side effect of chemotherapy. Over time, it is anticipated that there would be an increase in the number of cancer patients receiving treatments that could harm their cardiovascular systems. Physicians should choose whether to continue, halt, delay, or reduce the dose of chemotherapeutic drugs to reduce the impact of cardiotoxicity. Cardiotoxicity screening and diagnosis need a variety of methods, primarily echocardiography to evaluate Left Ventricular Ejection Fraction (LVEF) and Global Longitudinal Strain (GLS). Depending on the clinical state, these procedures may be carried out prior to, during, or following chemotherapy. It’s critical to reduce cardiovascular risk factors and offer advice on leading a healthy lifestyle before giving cancer patients medicines. There are a lot of cancer treatment facilities all around the world that don’t have evidence-based perspective cardiotoxicity scores to stratify the risk of cardiovascular problems caused by cancer therapy. Additionally, comorbid conditions like diabetes and hypertension are frequently present in cancer patients, which can have a significant impact on clinical outcomes and cancer treatment. Therefore, this article aims to discuss assessment methods, clinical practice guidance, and prevention of CTRCD.https://actamedindones.org/index.php/ijim/article/view/2440cardiac diseasecardiotoxicityctrcdchemotherapycancer |
| spellingShingle | Muhammad Yamin Simon Salim Muhammad Syahrir Azizi Lusiani Rusdi Aru Wisaksono Sudoyo Anneira Amanda Putri Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy Acta Medica Indonesiana cardiac disease cardiotoxicity ctrcd chemotherapy cancer |
| title | Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy |
| title_full | Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy |
| title_fullStr | Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy |
| title_full_unstemmed | Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy |
| title_short | Advancing The Cardiovascular Care in Cancer Patients on Chemotherapy |
| title_sort | advancing the cardiovascular care in cancer patients on chemotherapy |
| topic | cardiac disease cardiotoxicity ctrcd chemotherapy cancer |
| url | https://actamedindones.org/index.php/ijim/article/view/2440 |
| work_keys_str_mv | AT muhammadyamin advancingthecardiovascularcareincancerpatientsonchemotherapy AT simonsalim advancingthecardiovascularcareincancerpatientsonchemotherapy AT muhammadsyahrirazizi advancingthecardiovascularcareincancerpatientsonchemotherapy AT lusianirusdi advancingthecardiovascularcareincancerpatientsonchemotherapy AT aruwisaksonosudoyo advancingthecardiovascularcareincancerpatientsonchemotherapy AT anneiraamandaputri advancingthecardiovascularcareincancerpatientsonchemotherapy |